Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury

World J Gastroenterol. 2021 Jun 14;27(22):2944-2962. doi: 10.3748/wjg.v27.i22.2944.

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is a global pandemic and poses a major threat to human health worldwide. In addition to respiratory symptoms, COVID-19 is usually accompanied by systemic inflammation and liver damage in moderate and severe cases. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that regulates the expression of antioxidant proteins, participating in COVID-19-mediated inflammation and liver injury. Here, we show the novel reciprocal regulation between NRF2 and inflammatory mediators associated with COVID-19-related liver injury. Additionally, we describe some mechanisms and treatment strategies.

Keywords: COVID-19-related liver injury; Inflammatory mediator; Nuclear factor erythroid 2-related factor 2; Oxidative stress; Therapeutic targets.

Publication types

  • Review

MeSH terms

  • COVID-19* / pathology
  • Humans
  • Inflammation Mediators* / metabolism
  • Liver / metabolism
  • Liver / pathology
  • Liver Diseases / virology*
  • NF-E2-Related Factor 2* / metabolism
  • Oxidative Stress
  • SARS-CoV-2
  • Signal Transduction

Substances

  • Inflammation Mediators
  • NF-E2-Related Factor 2